Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Heron Therapeutics (HRTX) Times Interest Earned (2016 - 2017)

Heron Therapeutics' Times Interest Earned history spans 4 years, with the latest figure at -$11.48 for Q3 2017.

  • For Q3 2017, Times Interest Earned changed N/A year-over-year to -$11.48; the TTM value through Jun 2018 reached -$94.66, down 45.44%, while the annual FY2025 figure was -$0.26, 86.17% up from the prior year.
  • Times Interest Earned reached -$11.48 in Q3 2017 per HRTX's latest filing, up from -$11.68 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$11.48 in Q3 2017 to a low of -$74.19 in Q2 2013.
  • Average Times Interest Earned over 3 years is -$42.66, with a median of -$60.59 recorded in 2013.
  • The largest YoY upside for Times Interest Earned was 168.72% in 2013 against a maximum downside of 168.72% in 2013.
  • A 3-year view of Times Interest Earned shows it stood at -$60.59 in 2013, then dropped by 4.89% to -$63.56 in 2016, then surged by 81.94% to -$11.48 in 2017.
  • Per Business Quant, the three most recent readings for HRTX's Times Interest Earned are -$11.48 (Q3 2017), -$11.68 (Q2 2017), and -$13.69 (Q1 2017).